Rights and permissions
About this article
Cite this article
Orlistat, paclitaxel + carboplatin & infliximab preferred by clinicians. Pharmacoecon. Outcomes News 621, 10 (2011). https://doi.org/10.2165/00151234-201106210-00024
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-201106210-00024